|
|
||||||||
Corresponding author: Sabina De Geest, RN, PhD, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, CH-4056 Basel, Switzerland (e-mail: sabina.degeest{at}unibas.ch).
Adherence to fluid restrictions and dietary and medication guidelines as well as attendance at prescribed hemodialysis sessions of a hemodialysis regimen are essential for adequate management of end-stage renal disease. A literature review was conducted to determine the prevalence and consequences of nonadherence to the different aspects of a hemodialysis regimen and the methodological obstacles in research on nonadherence. Nonadherence to the prescribed regimen is a common problem in hemodialysis and is associated with increased morbidity and mortality. Research on nonadherence is associated with 2 major obstacles: inconsistencies in definitions and invalid measurement methods. Further research is needed to validate measurement methods and to establish clinically relevant operational definitions of nonadherence.
|
Notice to CE enrollees: A closed-book, multiple-choice examination following this article tests your understanding of the following objectives:
To read this article and take the CE test online, visit www.ajcconline.org and click "CE Articles in This Issue."
|
This article has been cited by other articles:
![]() |
S. van Dijk, M. Scharloo, A. A. Kaptein, M. S. Y. Thong, E. W. Boeschoten, D. C. Grootendorst, R. T. Krediet, F. W. Dekker, and for the NECOSAD Study Group Patients' representations of their end-stage renal disease: relation with mortality Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3183 - 3185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sood, C. Rigatto, J. Bueti, C. Lang, L. Miller, A. PonnamPalam, M. Reslerova, A. Sood, and P. Komenda Thrice weekly warfarin administration in haemodialysis patients Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3162 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S Matza, J. Park, K. S Coyne, E. P Skinner, K. G Malley, and R. Q Wolever Derivation and Validation of the ASK-12 Adherence Barrier Survey Ann. Pharmacother., October 1, 2009; 43(10): 1621 - 1630. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |